Accession Number: | 0001209191-20-046009 |
Date: | 2020-08-06 |
Issuer: | BIOLASE, INC (BIOL) |
Original Submission Date: |
BEAVER JOHN R
4 CROMWELL
IRVINE, CA 92618
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNIT | 0.0 | 2020-08-06 | deemed execution date | A | 200,000 (a) | common stock 200,000 | $0.00 | 250,692 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents the right to receive, at settlement, one share of common stock. |
f2 | the restricted stock unit award vests as follows: (i) one-half of the restricted stock units shall vest on the twelve-month anniversary of date of grant, and (ii) one-half of the restricted stock units shall vest in accordance with performance criteria established by the compensation committee of the company, in each case subject to the reporting person's continued service with the company. |